Anthropic：影響微軟365連接器的錯誤已解決。

Nov 14 — China’s National Healthcare Security Administration said JW Therapeutics’ CAR-T drug Ruijiaolunsai has been added to the National Reimbursement Drug List. The therapy’s list price was 1.29 mln yuan per dose prior to inclusion; inclusion has cut the price to below 300,000 yuan per dose, according to Ma Jun, director of the Harbin Institute of Hematology and Oncology, who took part in the drug’s review and clinical-consensus drafting.

歐洲航空安全組織：應美國聯邦航空局要求，因技術問題，協調世界時（UTC）13日22時至14日5時（北京時間14日6時至13時），從該組織成員國出發飛往美國機場的所有航班暫停起飛。